IMMX icon

Immix Biopharma
IMMX

Overview Fund Activity

28 hedge funds and large institutions have $5.43M invested in Immix Biopharma in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
28
Holders Change
+12
Holders Change %
+75%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
7
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EI
1
EAM Investors
California
$710K
2
PAG
2
Private Advisor Group
New Jersey
$690K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.11M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$224K
5
Morgan Stanley
5
Morgan Stanley
New York
$224K

Top Sellers

1
Koshinski Asset Management
1
Koshinski Asset Management
Illinois
$0
2
ICG
2
InterOcean Capital Group
Tennessee
$82.3K
3
Commonwealth Equity Services
3
Commonwealth Equity Services
Massachusetts
$196K
4
BlackRock
4
BlackRock
New York
$123K
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$2.71K +$2.31K +334 +586%
Osaic Holdings
27
Osaic Holdings
Arizona
$2.42K – – –
Koshinski Asset Management
28
Koshinski Asset Management
Illinois
– -$174K -51,001 Closed
1
2